India
· Delayed Price · Currency is INR Vivo Bio Tech Statistics
Total Valuation
Vivo Bio Tech has a market cap or net worth of INR 686.10 million. The enterprise value is 1.25 billion.
| Market Cap | 686.10M |
| Enterprise Value | 1.25B |
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivo Bio Tech has 17.48 million shares outstanding. The number of shares has increased by 11.16% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 17.48M |
| Shares Change (YoY) | +11.16% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 15.81% |
| Owned by Institutions (%) | n/a |
| Float | 3.47M |
Valuation Ratios
The trailing PE ratio is 9.44.
| PE Ratio | 9.44 |
| Forward PE | n/a |
| PS Ratio | 1.49 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 1.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 17.99 |
| EV / Sales | 2.71 |
| EV / EBITDA | 6.62 |
| EV / EBIT | 10.72 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.97 |
| Debt / EBITDA | 3.06 |
| Debt / FCF | n/a |
| Interest Coverage | 1.59 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.33% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 2.87M |
| Profits Per Employee | 432,050 |
| Employee Count | 161 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.85% in the last 52 weeks. The beta is 0.67, so Vivo Bio Tech's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -13.85% |
| 50-Day Moving Average | 38.13 |
| 200-Day Moving Average | 39.05 |
| Relative Strength Index (RSI) | 56.40 |
| Average Volume (20 Days) | 37,278 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vivo Bio Tech had revenue of INR 461.40 million and earned 69.56 million in profits. Earnings per share was 4.16.
| Revenue | 461.40M |
| Gross Profit | 398.04M |
| Operating Income | 116.67M |
| Pretax Income | 89.86M |
| Net Income | 69.56M |
| EBITDA | 188.87M |
| EBIT | 116.67M |
| Earnings Per Share (EPS) | 4.16 |
Balance Sheet
The company has 13.70 million in cash and 578.83 million in debt, giving a net cash position of -565.13 million or -32.34 per share.
| Cash & Cash Equivalents | 13.70M |
| Total Debt | 578.83M |
| Net Cash | -565.13M |
| Net Cash Per Share | -32.34 |
| Equity (Book Value) | 597.99M |
| Book Value Per Share | 40.11 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 86.27%, with operating and profit margins of 25.29% and 15.08%.
| Gross Margin | 86.27% |
| Operating Margin | 25.29% |
| Pretax Margin | 19.48% |
| Profit Margin | 15.08% |
| EBITDA Margin | 40.93% |
| EBIT Margin | 25.29% |
| FCF Margin | n/a |
Dividends & Yields
Vivo Bio Tech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.16% |
| Shareholder Yield | -11.16% |
| Earnings Yield | 10.14% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 7, 2005. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 7, 2005 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |